Skip to Content
Regeneron Pharmaceuticals Inc. Logo.
news / Press Releases

Press Releases

February 10, 2026 7:00 AM EST

Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy

Read press release : Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy

February 2, 2026 7:00 AM EST

EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases

Read press release : EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases

January 30, 2026 6:30 AM EST

Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Read press release : Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

January 21, 2026 12:00 PM EST

Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search

Read press release : Nation’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at the Prestigious Regeneron Science Talent Search

January 2, 2026 4:05 PM EST

Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026

Read press release : Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026
Back to top